Flynn, Bernard Luke,Dharam, Paul,Harvey, Andrew John,Sethuraman, Vasu V.,Forslund, Raymond E.,Xue, Song,Livingston, Rob,Hashash, Ahmad
申请号：
AU2014231722
公开号：
AU2014231722A1
申请日:
2014.03.14
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention provides amorphous arid crystalline forms of 1-ethyl-6-(indan-2- ylamino)-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one (compound 1), and salts, co- crystals, and pharmaceutical compositions thereof. The invention also provides methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using the amorphous and crystelline forms, and salts, co-crystals, and pharmaceutical compositions thereof.
